Modeling ER+ breast cancer dormancy in mice

被引：0
|
作者：
Alexandra Le Bras
机构：
[1] Lab Animal,
来源：
Lab Animal | 2022年 / 51卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：285 / 285
相关论文
共 50 条
  • [21] YAP inhibits ERα and ER+ breast cancer growth by disrupting a TEAD-ERα signaling axis
    Xu Li
    Shu Zhuo
    Ting Zhuang
    Yong Suk Cho
    Guojin Wu
    Yuchen Liu
    Kun Mu
    Kai Zhang
    Peng Su
    Yingzi Yang
    Cheng Cheng Zhang
    Jian Zhu
    Jin Jiang
    [J]. Nature Communications, 13
  • [22] YAP inhibits ERα and ER+ breast cancer growth by disrupting a TEAD-ERα signaling axis
    Li, Xu
    Zhuo, Shu
    Zhuang, Ting
    Cho, Yong Suk
    Wu, Guojin
    Liu, Yuchen
    Mu, Kun
    Zhang, Kai
    Su, Peng
    Yang, Yingzi
    Zhang, Cheng Cheng
    Zhu, Jian
    Jiang, Jin
    [J]. NATURE COMMUNICATIONS, 2022, 13 (01)
  • [23] MSK1 regulates luminal cell differentiation and metastatic dormancy in ER+ breast cancer (vol 20, pg 211, 2018)
    Gawrzak, Sylwia
    Rinaldi, Lorenzo
    Gregorio, Sara
    Arenas, Enrique J.
    Salvador, Fernando
    Urosevic, Jelena
    Figueras-Puig, Cristina
    Rojo, Federico
    Barrantes, Ivan del Barco
    Cejalvo, Juan Miguel
    Palafox, Marta
    Guiu, Marc
    Berenguer-Llergo, Antonio
    Symeonidi, Aikaterini
    Bellmunt, Anna
    Kalafatovic, Daniela
    Arnal-Estape, Anna
    Fernandez, Esther
    Mullauer, Barbara
    Groeneveld, Rianne
    Slobodnyuk, Konstantin
    Attolini, Camille Stephan-Otto
    Saura, Cristina
    Arribas, Joaquin
    Cortes, Javier
    Rovira, Ana
    Munoz, Montse
    Lluch, Ana
    Serra, Violeta
    Albanell, Joan
    Prat, Aleix
    Nebreda, Angel R.
    Benitah, Salvador Aznar
    Gomis, Roger R.
    [J]. NATURE CELL BIOLOGY, 2018, 20 (08) : 990 - 990
  • [24] In vivo model of dormancy in ER breast cancer to bone metastasis
    Gawrzak, S.
    Guiu, M.
    Urosevic, J.
    Fernandez, E.
    Pavlovic, M.
    Gomis, R. R.
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 : S82 - S82
  • [25] Methylome Variation Predicts Exemestane Resistance in Advanced ER+ Breast Cancer
    Liu, Xiao-ran
    Zhang, Ru-yan
    Gong, Hao
    Rugo, Hope S.
    Chen, Ling-bo
    Fu, Yuan
    Che, Jian-wei
    Tie, Jian
    Shao, Bin
    Wan, Feng-ling
    Kong, Wei-yao
    Song, Guo-hong
    Jiang, Han-fang
    Xu, Guo-bing
    Li, Hui-ping
    [J]. TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2020, 19
  • [26] Targeted therapies for ER+/HER2-metastatic breast cancer
    Yamamoto-Ibusuki, Mutsuko
    Arnedos, Monica
    Andre, Fabrice
    [J]. BMC MEDICINE, 2015, 13
  • [27] Estetrol for treatment of advanced ER+/HER2-breast cancer
    Schmidt, Marcus
    Hoenig, Arnd
    Zimmerman, Yvette
    Verhoeven, Carole
    Almstedt, Katrin
    Battista, Marco
    Lenhard, Hans Georg
    Krijgh, Jan
    Bennink, Herjan Coelingh
    [J]. CANCER RESEARCH, 2020, 80 (04)
  • [28] Palbociclib Ups PFS in HER2-/ER+ Breast Cancer
    不详
    [J]. CANCER DISCOVERY, 2014, 4 (06) : 624 - 625
  • [29] Hydroxychloroquine Inhibits Autophagy to Potentiate Antiestrogen Responsiveness in ER+ Breast Cancer
    Cook, Katherine L.
    Waerri, Anni
    Soto-Pantoja, David R.
    Clarke, Pamela A. G.
    Cruz, M. Idalia
    Zwart, Alan
    Clarke, Robert
    [J]. CLINICAL CANCER RESEARCH, 2014, 20 (12) : 3222 - 3232
  • [30] Targeted therapies for ER+/HER2- metastatic breast cancer
    Mutsuko Yamamoto-Ibusuki
    Monica Arnedos
    Fabrice André
    [J]. BMC Medicine, 13
12345